Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 11:12 AM
Ignite Modification Date:
2025-12-26 @ 11:12 AM
NCT ID:
NCT03634228
Group ID:
EG000
Title:
Phase I (Low Dose Cytarabine, MDM2 Inhibitor DS-3032b) Cohort 0
Description:
Patients receive low dose cytarabine SC BID on days 1-10 and milademetan tosylate PO QD on days 8-14, 8-21, or 5-7 and 15-17. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.
Cytarabine: Given SC
Milademetan Tosylate: Given 120 mg PO
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
3
Other Number Affected:
2
Other Number At Risk:
3
Study:
NCT03634228
Results Section:
NCT03634228
Adverse Events Module:
NCT03634228